Beliefs about the causes of depression and recovery and their impact on adherence, dosage, and successful tapering of antidepressants.

Saved in:
Bibliographic Details
Title: Beliefs about the causes of depression and recovery and their impact on adherence, dosage, and successful tapering of antidepressants.
Authors: Klein, Nicola S., Rijsbergen, Gerard D., ten Doesschate, Mascha C., Hollon, Steven D., Burger, Huibert, Bockting, Claudi L. H.
Source: Depression & Anxiety (1091-4269). Mar2017, Vol. 34 Issue 3, p227-235. 9p. 5 Charts.
Subjects: Antidepressants, Mental depression, Therapeutics, Patient compliance, Drug dosage, Drug efficacy, Disease relapse prevention, Cognitive therapy, Comparative studies, Drugs, Dose-effect relationship in pharmacology, Health attitudes, Research methodology, Medical cooperation, Research, Evaluation research, Randomized controlled trials, Disease remission
Abstract: Background: Continuation of antidepressant medication (ADM) after remission is widely used to prevent depressive relapse/recurrence. Little is known about predictors of ADM use in terms of adherence, dosage, and successful tapering. The current study aimed to explore beliefs about the causes of depression and recovery (i.e., causal beliefs) and to examine whether they predict ADM use.Methods: The data were drawn from a controlled trial and an extension of this trial with additional experience sampling. In total, 289 remitted patients with recurrent depression (ADM ≥ 6 months) were randomly assigned to Preventive Cognitive Therapy (PCT) with ADM tapering, PCT with maintenance ADM, or maintenance ADM alone. Adherence, ADM dosage, and causal beliefs regarding the first and last depressive episodes were explored via questionnaires.Results: Most patients mentioned stressful life events as cause of depression, although more patients tended to endorse external causes for the first episode and internal causes for the last episode. ADM was most often mentioned as helpful during recovery from both episodes. Over half of all patients were adherent and under half of the patients in the tapering condition were able to complete the taper. Causal beliefs did not predict ADM use.Conclusions: The results suggest that causal beliefs play little role in the use of maintenance ADM. More information is needed on factors contributing to successful tapering. The results must be interpreted with caution as this is not a naturalistic study and the results might be biased toward a more favorable view regarding ADM. [ABSTRACT FROM AUTHOR]
Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 121609143
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Beliefs about the causes of depression and recovery and their impact on adherence, dosage, and successful tapering of antidepressants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Klein%2C+Nicola+S%2E%22">Klein, Nicola S.</searchLink><br /><searchLink fieldCode="AR" term="%22Rijsbergen%2C+Gerard+D%2E%22">Rijsbergen, Gerard D.</searchLink><br /><searchLink fieldCode="AR" term="%22ten+Doesschate%2C+Mascha+C%2E%22">ten Doesschate, Mascha C.</searchLink><br /><searchLink fieldCode="AR" term="%22Hollon%2C+Steven+D%2E%22">Hollon, Steven D.</searchLink><br /><searchLink fieldCode="AR" term="%22Burger%2C+Huibert%22">Burger, Huibert</searchLink><br /><searchLink fieldCode="AR" term="%22Bockting%2C+Claudi+L%2E+H%2E%22">Bockting, Claudi L. H.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Depression+%26+Anxiety+%281091-4269%29%22">Depression & Anxiety (1091-4269)</searchLink>. Mar2017, Vol. 34 Issue 3, p227-235. 9p. 5 Charts.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Antidepressants%22">Antidepressants</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+compliance%22">Patient compliance</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+dosage%22">Drug dosage</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+efficacy%22">Drug efficacy</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+relapse+prevention%22">Disease relapse prevention</searchLink><br /><searchLink fieldCode="DE" term="%22Cognitive+therapy%22">Cognitive therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Comparative+studies%22">Comparative studies</searchLink><br /><searchLink fieldCode="DE" term="%22Drugs%22">Drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Dose-effect+relationship+in+pharmacology%22">Dose-effect relationship in pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22Health+attitudes%22">Health attitudes</searchLink><br /><searchLink fieldCode="DE" term="%22Research+methodology%22">Research methodology</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+cooperation%22">Medical cooperation</searchLink><br /><searchLink fieldCode="DE" term="%22Research%22">Research</searchLink><br /><searchLink fieldCode="DE" term="%22Evaluation+research%22">Evaluation research</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+controlled+trials%22">Randomized controlled trials</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+remission%22">Disease remission</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: <bold>Background: </bold>Continuation of antidepressant medication (ADM) after remission is widely used to prevent depressive relapse/recurrence. Little is known about predictors of ADM use in terms of adherence, dosage, and successful tapering. The current study aimed to explore beliefs about the causes of depression and recovery (i.e., causal beliefs) and to examine whether they predict ADM use.<bold>Methods: </bold>The data were drawn from a controlled trial and an extension of this trial with additional experience sampling. In total, 289 remitted patients with recurrent depression (ADM ≥ 6 months) were randomly assigned to Preventive Cognitive Therapy (PCT) with ADM tapering, PCT with maintenance ADM, or maintenance ADM alone. Adherence, ADM dosage, and causal beliefs regarding the first and last depressive episodes were explored via questionnaires.<bold>Results: </bold>Most patients mentioned stressful life events as cause of depression, although more patients tended to endorse external causes for the first episode and internal causes for the last episode. ADM was most often mentioned as helpful during recovery from both episodes. Over half of all patients were adherent and under half of the patients in the tapering condition were able to complete the taper. Causal beliefs did not predict ADM use.<bold>Conclusions: </bold>The results suggest that causal beliefs play little role in the use of maintenance ADM. More information is needed on factors contributing to successful tapering. The results must be interpreted with caution as this is not a naturalistic study and the results might be biased toward a more favorable view regarding ADM. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=121609143
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/da.22598
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 227
    Subjects:
      – SubjectFull: Antidepressants
        Type: general
      – SubjectFull: Mental depression
        Type: general
      – SubjectFull: Therapeutics
        Type: general
      – SubjectFull: Patient compliance
        Type: general
      – SubjectFull: Drug dosage
        Type: general
      – SubjectFull: Drug efficacy
        Type: general
      – SubjectFull: Disease relapse prevention
        Type: general
      – SubjectFull: Cognitive therapy
        Type: general
      – SubjectFull: Comparative studies
        Type: general
      – SubjectFull: Drugs
        Type: general
      – SubjectFull: Dose-effect relationship in pharmacology
        Type: general
      – SubjectFull: Health attitudes
        Type: general
      – SubjectFull: Research methodology
        Type: general
      – SubjectFull: Medical cooperation
        Type: general
      – SubjectFull: Research
        Type: general
      – SubjectFull: Evaluation research
        Type: general
      – SubjectFull: Randomized controlled trials
        Type: general
      – SubjectFull: Disease remission
        Type: general
    Titles:
      – TitleFull: Beliefs about the causes of depression and recovery and their impact on adherence, dosage, and successful tapering of antidepressants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Klein, Nicola S.
      – PersonEntity:
          Name:
            NameFull: Rijsbergen, Gerard D.
      – PersonEntity:
          Name:
            NameFull: ten Doesschate, Mascha C.
      – PersonEntity:
          Name:
            NameFull: Hollon, Steven D.
      – PersonEntity:
          Name:
            NameFull: Burger, Huibert
      – PersonEntity:
          Name:
            NameFull: Bockting, Claudi L. H.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2017
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-print
              Value: 10914269
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Depression & Anxiety (1091-4269)
              Type: main
ResultId 1